Sarasota Memorial Joins International Study to Prevent Atrial Fibrillation After Heart Surgery

Sarasota Memorial Joins International Study to Prevent Atrial Fibrillation After Heart Surgery

New-onset atrial fibrillation (AFib) is one of the most common complications after heart surgery, affecting up to 50% of patients and often leading to longer hospital stays, reduced quality of life, and increased risks of stroke, heart failure and death. Researchers at Sarasota Memorial’s Kolschowsky Research and Education Institute are working to address this challenge through participation in the BoxX-NoAF clinical trial, a multicenter international study sponsored by AtriCure.

Thursday, April 16, 2026
Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer

Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer

Sarasota Memorial Health Care System (SMH) has enrolled the first patient in a clinical study evaluating the safety and effectiveness of a novel, minimally invasive treatment for papillary thyroid cancer (PTC) using Pulse Biosciences’ nPulse™ technology.

Monday, March 30, 2026
Sarasota Memorial Studies Novel Pacing Approach for Heart Failure Patients

Sarasota Memorial Studies Novel Pacing Approach for Heart Failure Patients

Sarasota Memorial’s Kolschowsky Research and Education Institute has joined an international clinical trial, SYNCHRONICITY, evaluating the safety and effectiveness of a new pacing approach for heart failure patients.

Wednesday, March 11, 2026
SMH research study enrolling patients with advanced skin cancer

SMH research study enrolling patients with advanced skin cancer

In search of improved treatment outcomes, Sarasota Memorial’s Kolschowsky Research and Education Institute is part of an international clinical trial enrolling qualified patients with advanced stage squamous cell skin cancer, also called cutaneous squamous cell carcinoma (CSCC). It is one of the most common types of skin cancer, often found in areas exposed to the sun, such as the head, neck and arms.

Tuesday, March 10, 2026
Sarasota Memorial Joins Clinical Trial for Patients with Aortic Valve Disease

Sarasota Memorial Joins Clinical Trial for Patients with Aortic Valve Disease

The new KATALYST-AV trial, sponsored by Kardigan, Inc aims to evaluate whether the investigational medication ataciguat can slow the buildup of calcium in the aortic valve in adults with moderate calcific aortic valve stenosis (CAVS).

Thursday, January 8, 2026
RSS
123